Cellular Biomedicine Group is Biotechnology in United States that focus on Biomedicine Group Inc business. Founded in 2001. They cover business area such as Cellular Biomedicine Group Inc, proprietary cell therapy, cancer, degenerative disease, two major cell platform, immune cell therapy, Chimeric Antigen Receptor T-cell technology, human-adipose-derive mesenchymal progenitor cell, treatment, joint and autoimmune disease, both China.
2001
( 25 years old in 2026 )
Biomedicine Group Inc
-
09 Perry Parkway
Suite 13
Gaithersburg, MD 20877
United States
Private
Cellular Biomedicine Group Incproprietary cell therapycancerdegenerative diseasetwo major cell platformimmune cell therapyChimeric Antigen Receptor T-cell technologyhuman-adipose-derive mesenchymal progenitor celltreatmentjoint and autoimmune diseaseboth China
* We use standard office opening hours in near Cellular Biomedicine Group's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cellular Biomedicine Group is Biotechnology business from United States that founded in 2001 (25 years old in 2026), Cellular Biomedicine Group business is focusing on Biomedicine Group Inc.
Cellular Biomedicine Group headquarter office and corporate office address is located in 09 Perry Parkway Suite 13 Gaithersburg, MD 20877 United States.
Cellular Biomedicine Group was founded in United States.
In 2026, Cellular Biomedicine Group is currently focus on Biomedicine Group Inc sector.
Above is snippet of Google Trends for "Biomedicine Group Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cellular Biomedicine Group, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
